Drugs / Shengmai Liquid
Shengmai Liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06980636 | Dec 2025 → Oct 2026 expected | long COVID-19 | Beijing University of Chinese Medicine | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shengmai Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06980636 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine Shengmaiyin oral liquid” NCT06980636 ↗ |
| Route | Oral | “taken orally at a dose of 10ml per time, three times a day” NCT06980636 ↗ |